Report Thumbnail
Product Code QY0914012486QYI
Published Date 2024/4/15
QY Research
English170 PagesGlobal

Coronary Intervention Drug Eluting Stent - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030 ‐ MedicalDevice_MedTech Market


Report Thumbnail
Product Code QY0914012486QYI◆The Apr 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2024/4/15
QY Research
English 170 PagesGlobal

Coronary Intervention Drug Eluting Stent - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030 ‐ MedicalDevice_MedTech Market


Abstract

Summary

The global market for Coronary Intervention Drug Eluting Stent was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Coronary Intervention Drug Eluting Stent, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Coronary Intervention Drug Eluting Stent by region & country, by Type, and by Application.
The Coronary Intervention Drug Eluting Stent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coronary Intervention Drug Eluting Stent.
Market Segmentation
By Company
Synlas GmbH
YILSON
BrosMed Medical
SCITECH Medical
Wellinq
Degania Silicone
Alvimedica
Interventional Medical Device Solutions
Comed BV
iVascular
LEPU Medical
Eurocor Tech GmbH
OrbusNeich
Endocor GmbH
Meril Life Sciences
Acrostak
Boston Scientific Corporation
B. Braun
Biotronik
Abbott
MicroPort Medical Group
Philips
Terumo Corporation
Segment by Type:
Below 40 µm
40 µm- 65 µm
Above 65 µm
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Coronary Intervention Drug Eluting Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Coronary Intervention Drug Eluting Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Coronary Intervention Drug Eluting Stent in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

  • 1 Market Overview

    • 1.1 Coronary Intervention Drug Eluting Stent Product Introduction
    • 1.2 Global Coronary Intervention Drug Eluting Stent Market Size Forecast
      • 1.2.1 Global Coronary Intervention Drug Eluting Stent Sales Value (2019-2030)
      • 1.2.2 Global Coronary Intervention Drug Eluting Stent Sales Volume (2019-2030)
      • 1.2.3 Global Coronary Intervention Drug Eluting Stent Sales Price (2019-2030)
    • 1.3 Coronary Intervention Drug Eluting Stent Market Trends & Drivers
      • 1.3.1 Coronary Intervention Drug Eluting Stent Industry Trends
      • 1.3.2 Coronary Intervention Drug Eluting Stent Market Drivers & Opportunity
      • 1.3.3 Coronary Intervention Drug Eluting Stent Market Challenges
      • 1.3.4 Coronary Intervention Drug Eluting Stent Market Restraints
    • 1.4 Assumptions and Limitations
    • 1.5 Study Objectives
    • 1.6 Years Considered

  • 2 Competitive Analysis by Company

    • 2.1 Global Coronary Intervention Drug Eluting Stent Players Revenue Ranking (2023)
    • 2.2 Global Coronary Intervention Drug Eluting Stent Revenue by Company (2019-2024)
    • 2.3 Global Coronary Intervention Drug Eluting Stent Players Sales Volume Ranking (2023)
    • 2.4 Global Coronary Intervention Drug Eluting Stent Sales Volume by Company Players (2019-2024)
    • 2.5 Global Coronary Intervention Drug Eluting Stent Average Price by Company (2019-2024)
    • 2.6 Key Manufacturers Coronary Intervention Drug Eluting Stent Manufacturing Base Distribution and Headquarters
    • 2.7 Key Manufacturers Coronary Intervention Drug Eluting Stent Product Offered
    • 2.8 Key Manufacturers Time to Begin Mass Production of Coronary Intervention Drug Eluting Stent
    • 2.9 Coronary Intervention Drug Eluting Stent Market Competitive Analysis
      • 2.9.1 Coronary Intervention Drug Eluting Stent Market Concentration Rate (2019-2024)
      • 2.9.2 Global 5 and 10 Largest Manufacturers by Coronary Intervention Drug Eluting Stent Revenue in 2023
      • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronary Intervention Drug Eluting Stent as of 2023)
    • 2.10 Mergers & Acquisitions, Expansion

  • 3 Segmentation by Type

    • 3.1 Introduction by Type
      • 3.1.1 Below 40 µm
      • 3.1.2 40 µm- 65 µm
      • 3.1.3 Above 65 µm
    • 3.2 Global Coronary Intervention Drug Eluting Stent Sales Value by Type
      • 3.2.1 Global Coronary Intervention Drug Eluting Stent Sales Value by Type (2019 VS 2023 VS 2030)
      • 3.2.2 Global Coronary Intervention Drug Eluting Stent Sales Value, by Type (2019-2030)
      • 3.2.3 Global Coronary Intervention Drug Eluting Stent Sales Value, by Type (%) (2019-2030)
    • 3.3 Global Coronary Intervention Drug Eluting Stent Sales Volume by Type
      • 3.3.1 Global Coronary Intervention Drug Eluting Stent Sales Volume by Type (2019 VS 2023 VS 2030)
      • 3.3.2 Global Coronary Intervention Drug Eluting Stent Sales Volume, by Type (2019-2030)
      • 3.3.3 Global Coronary Intervention Drug Eluting Stent Sales Volume, by Type (%) (2019-2030)
    • 3.4 Global Coronary Intervention Drug Eluting Stent Average Price by Type (2019-2030)

  • 4 Segmentation by Application

    • 4.1 Introduction by Application
      • 4.1.1 Hospital
      • 4.1.2 Clinic
      • 4.1.3 Others
    • 4.2 Global Coronary Intervention Drug Eluting Stent Sales Value by Application
      • 4.2.1 Global Coronary Intervention Drug Eluting Stent Sales Value by Application (2019 VS 2023 VS 2030)
      • 4.2.2 Global Coronary Intervention Drug Eluting Stent Sales Value, by Application (2019-2030)
      • 4.2.3 Global Coronary Intervention Drug Eluting Stent Sales Value, by Application (%) (2019-2030)
    • 4.3 Global Coronary Intervention Drug Eluting Stent Sales Volume by Application
      • 4.3.1 Global Coronary Intervention Drug Eluting Stent Sales Volume by Application (2019 VS 2023 VS 2030)
      • 4.3.2 Global Coronary Intervention Drug Eluting Stent Sales Volume, by Application (2019-2030)
      • 4.3.3 Global Coronary Intervention Drug Eluting Stent Sales Volume, by Application (%) (2019-2030)
    • 4.4 Global Coronary Intervention Drug Eluting Stent Average Price by Application (2019-2030)

  • 5 Segmentation by Region

    • 5.1 Global Coronary Intervention Drug Eluting Stent Sales Value by Region
      • 5.1.1 Global Coronary Intervention Drug Eluting Stent Sales Value by Region: 2019 VS 2023 VS 2030
      • 5.1.2 Global Coronary Intervention Drug Eluting Stent Sales Value by Region (2019-2024)
      • 5.1.3 Global Coronary Intervention Drug Eluting Stent Sales Value by Region (2025-2030)
      • 5.1.4 Global Coronary Intervention Drug Eluting Stent Sales Value by Region (%), (2019-2030)
    • 5.2 Global Coronary Intervention Drug Eluting Stent Sales Volume by Region
      • 5.2.1 Global Coronary Intervention Drug Eluting Stent Sales Volume by Region: 2019 VS 2023 VS 2030
      • 5.2.2 Global Coronary Intervention Drug Eluting Stent Sales Volume by Region (2019-2024)
      • 5.2.3 Global Coronary Intervention Drug Eluting Stent Sales Volume by Region (2025-2030)
      • 5.2.4 Global Coronary Intervention Drug Eluting Stent Sales Volume by Region (%), (2019-2030)
    • 5.3 Global Coronary Intervention Drug Eluting Stent Average Price by Region (2019-2030)
    • 5.4 North America
      • 5.4.1 North America Coronary Intervention Drug Eluting Stent Sales Value, 2019-2030
      • 5.4.2 North America Coronary Intervention Drug Eluting Stent Sales Value by Country (%), 2023 VS 2030
    • 5.5 Europe
      • 5.5.1 Europe Coronary Intervention Drug Eluting Stent Sales Value, 2019-2030
      • 5.5.2 Europe Coronary Intervention Drug Eluting Stent Sales Value by Country (%), 2023 VS 2030
    • 5.6 Asia Pacific
      • 5.6.1 Asia Pacific Coronary Intervention Drug Eluting Stent Sales Value, 2019-2030
      • 5.6.2 Asia Pacific Coronary Intervention Drug Eluting Stent Sales Value by Country (%), 2023 VS 2030
    • 5.7 South America
      • 5.7.1 South America Coronary Intervention Drug Eluting Stent Sales Value, 2019-2030
      • 5.7.2 South America Coronary Intervention Drug Eluting Stent Sales Value by Country (%), 2023 VS 2030
    • 5.8 Middle East & Africa
      • 5.8.1 Middle East & Africa Coronary Intervention Drug Eluting Stent Sales Value, 2019-2030
      • 5.8.2 Middle East & Africa Coronary Intervention Drug Eluting Stent Sales Value by Country (%), 2023 VS 2030

  • 6 Segmentation by Key Countries/Regions

    • 6.1 Key Countries/Regions Coronary Intervention Drug Eluting Stent Sales Value Growth Trends, 2019 VS 2023 VS 2030
    • 6.2 Key Countries/Regions Coronary Intervention Drug Eluting Stent Sales Value
      • 6.2.1 Key Countries/Regions Coronary Intervention Drug Eluting Stent Sales Value, 2019-2030
      • 6.2.2 Key Countries/Regions Coronary Intervention Drug Eluting Stent Sales Volume, 2019-2030
    • 6.3 United States
      • 6.3.1 United States Coronary Intervention Drug Eluting Stent Sales Value, 2019-2030
      • 6.3.2 United States Coronary Intervention Drug Eluting Stent Sales Value by Type (%), 2023 VS 2030
      • 6.3.3 United States Coronary Intervention Drug Eluting Stent Sales Value by Application, 2023 VS 2030
    • 6.4 Europe
      • 6.4.1 Europe Coronary Intervention Drug Eluting Stent Sales Value, 2019-2030
      • 6.4.2 Europe Coronary Intervention Drug Eluting Stent Sales Value by Type (%), 2023 VS 2030
      • 6.4.3 Europe Coronary Intervention Drug Eluting Stent Sales Value by Application, 2023 VS 2030
    • 6.5 China
      • 6.5.1 China Coronary Intervention Drug Eluting Stent Sales Value, 2019-2030
      • 6.5.2 China Coronary Intervention Drug Eluting Stent Sales Value by Type (%), 2023 VS 2030
      • 6.5.3 China Coronary Intervention Drug Eluting Stent Sales Value by Application, 2023 VS 2030
    • 6.6 Japan
      • 6.6.1 Japan Coronary Intervention Drug Eluting Stent Sales Value, 2019-2030
      • 6.6.2 Japan Coronary Intervention Drug Eluting Stent Sales Value by Type (%), 2023 VS 2030
      • 6.6.3 Japan Coronary Intervention Drug Eluting Stent Sales Value by Application, 2023 VS 2030
    • 6.7 South Korea
      • 6.7.1 South Korea Coronary Intervention Drug Eluting Stent Sales Value, 2019-2030
      • 6.7.2 South Korea Coronary Intervention Drug Eluting Stent Sales Value by Type (%), 2023 VS 2030
      • 6.7.3 South Korea Coronary Intervention Drug Eluting Stent Sales Value by Application, 2023 VS 2030
    • 6.8 Southeast Asia
      • 6.8.1 Southeast Asia Coronary Intervention Drug Eluting Stent Sales Value, 2019-2030
      • 6.8.2 Southeast Asia Coronary Intervention Drug Eluting Stent Sales Value by Type (%), 2023 VS 2030
      • 6.8.3 Southeast Asia Coronary Intervention Drug Eluting Stent Sales Value by Application, 2023 VS 2030
    • 6.9 India
      • 6.9.1 India Coronary Intervention Drug Eluting Stent Sales Value, 2019-2030
      • 6.9.2 India Coronary Intervention Drug Eluting Stent Sales Value by Type (%), 2023 VS 2030
      • 6.9.3 India Coronary Intervention Drug Eluting Stent Sales Value by Application, 2023 VS 2030

  • 7 Company Profiles

    • 7.1 Synlas GmbH
      • 7.1.1 Synlas GmbH Company Information
      • 7.1.2 Synlas GmbH Introduction and Business Overview
      • 7.1.3 Synlas GmbH Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
      • 7.1.4 Synlas GmbH Coronary Intervention Drug Eluting Stent Product Offerings
      • 7.1.5 Synlas GmbH Recent Development
    • 7.2 YILSON
      • 7.2.1 YILSON Company Information
      • 7.2.2 YILSON Introduction and Business Overview
      • 7.2.3 YILSON Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
      • 7.2.4 YILSON Coronary Intervention Drug Eluting Stent Product Offerings
      • 7.2.5 YILSON Recent Development
    • 7.3 BrosMed Medical
      • 7.3.1 BrosMed Medical Company Information
      • 7.3.2 BrosMed Medical Introduction and Business Overview
      • 7.3.3 BrosMed Medical Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
      • 7.3.4 BrosMed Medical Coronary Intervention Drug Eluting Stent Product Offerings
      • 7.3.5 BrosMed Medical Recent Development
    • 7.4 SCITECH Medical
      • 7.4.1 SCITECH Medical Company Information
      • 7.4.2 SCITECH Medical Introduction and Business Overview
      • 7.4.3 SCITECH Medical Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
      • 7.4.4 SCITECH Medical Coronary Intervention Drug Eluting Stent Product Offerings
      • 7.4.5 SCITECH Medical Recent Development
    • 7.5 Wellinq
      • 7.5.1 Wellinq Company Information
      • 7.5.2 Wellinq Introduction and Business Overview
      • 7.5.3 Wellinq Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
      • 7.5.4 Wellinq Coronary Intervention Drug Eluting Stent Product Offerings
      • 7.5.5 Wellinq Recent Development
    • 7.6 Degania Silicone
      • 7.6.1 Degania Silicone Company Information
      • 7.6.2 Degania Silicone Introduction and Business Overview
      • 7.6.3 Degania Silicone Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
      • 7.6.4 Degania Silicone Coronary Intervention Drug Eluting Stent Product Offerings
      • 7.6.5 Degania Silicone Recent Development
    • 7.7 Alvimedica
      • 7.7.1 Alvimedica Company Information
      • 7.7.2 Alvimedica Introduction and Business Overview
      • 7.7.3 Alvimedica Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
      • 7.7.4 Alvimedica Coronary Intervention Drug Eluting Stent Product Offerings
      • 7.7.5 Alvimedica Recent Development
    • 7.8 Interventional Medical Device Solutions
      • 7.8.1 Interventional Medical Device Solutions Company Information
      • 7.8.2 Interventional Medical Device Solutions Introduction and Business Overview
      • 7.8.3 Interventional Medical Device Solutions Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
      • 7.8.4 Interventional Medical Device Solutions Coronary Intervention Drug Eluting Stent Product Offerings
      • 7.8.5 Interventional Medical Device Solutions Recent Development
    • 7.9 Comed BV
      • 7.9.1 Comed BV Company Information
      • 7.9.2 Comed BV Introduction and Business Overview
      • 7.9.3 Comed BV Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
      • 7.9.4 Comed BV Coronary Intervention Drug Eluting Stent Product Offerings
      • 7.9.5 Comed BV Recent Development
    • 7.10 iVascular
      • 7.10.1 iVascular Company Information
      • 7.10.2 iVascular Introduction and Business Overview
      • 7.10.3 iVascular Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
      • 7.10.4 iVascular Coronary Intervention Drug Eluting Stent Product Offerings
      • 7.10.5 iVascular Recent Development
    • 7.11 LEPU Medical
      • 7.11.1 LEPU Medical Company Information
      • 7.11.2 LEPU Medical Introduction and Business Overview
      • 7.11.3 LEPU Medical Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
      • 7.11.4 LEPU Medical Coronary Intervention Drug Eluting Stent Product Offerings
      • 7.11.5 LEPU Medical Recent Development
    • 7.12 Eurocor Tech GmbH
      • 7.12.1 Eurocor Tech GmbH Company Information
      • 7.12.2 Eurocor Tech GmbH Introduction and Business Overview
      • 7.12.3 Eurocor Tech GmbH Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
      • 7.12.4 Eurocor Tech GmbH Coronary Intervention Drug Eluting Stent Product Offerings
      • 7.12.5 Eurocor Tech GmbH Recent Development
    • 7.13 OrbusNeich
      • 7.13.1 OrbusNeich Company Information
      • 7.13.2 OrbusNeich Introduction and Business Overview
      • 7.13.3 OrbusNeich Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
      • 7.13.4 OrbusNeich Coronary Intervention Drug Eluting Stent Product Offerings
      • 7.13.5 OrbusNeich Recent Development
    • 7.14 Endocor GmbH
      • 7.14.1 Endocor GmbH Company Information
      • 7.14.2 Endocor GmbH Introduction and Business Overview
      • 7.14.3 Endocor GmbH Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
      • 7.14.4 Endocor GmbH Coronary Intervention Drug Eluting Stent Product Offerings
      • 7.14.5 Endocor GmbH Recent Development
    • 7.15 Meril Life Sciences
      • 7.15.1 Meril Life Sciences Company Information
      • 7.15.2 Meril Life Sciences Introduction and Business Overview
      • 7.15.3 Meril Life Sciences Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
      • 7.15.4 Meril Life Sciences Coronary Intervention Drug Eluting Stent Product Offerings
      • 7.15.5 Meril Life Sciences Recent Development
    • 7.16 Acrostak
      • 7.16.1 Acrostak Company Information
      • 7.16.2 Acrostak Introduction and Business Overview
      • 7.16.3 Acrostak Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
      • 7.16.4 Acrostak Coronary Intervention Drug Eluting Stent Product Offerings
      • 7.16.5 Acrostak Recent Development
    • 7.17 Boston Scientific Corporation
      • 7.17.1 Boston Scientific Corporation Company Information
      • 7.17.2 Boston Scientific Corporation Introduction and Business Overview
      • 7.17.3 Boston Scientific Corporation Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
      • 7.17.4 Boston Scientific Corporation Coronary Intervention Drug Eluting Stent Product Offerings
      • 7.17.5 Boston Scientific Corporation Recent Development
    • 7.18 B. Braun
      • 7.18.1 B. Braun Company Information
      • 7.18.2 B. Braun Introduction and Business Overview
      • 7.18.3 B. Braun Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
      • 7.18.4 B. Braun Coronary Intervention Drug Eluting Stent Product Offerings
      • 7.18.5 B. Braun Recent Development
    • 7.19 Biotronik
      • 7.19.1 Biotronik Company Information
      • 7.19.2 Biotronik Introduction and Business Overview
      • 7.19.3 Biotronik Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
      • 7.19.4 Biotronik Coronary Intervention Drug Eluting Stent Product Offerings
      • 7.19.5 Biotronik Recent Development
    • 7.20 Abbott
      • 7.20.1 Abbott Company Information
      • 7.20.2 Abbott Introduction and Business Overview
      • 7.20.3 Abbott Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
      • 7.20.4 Abbott Coronary Intervention Drug Eluting Stent Product Offerings
      • 7.20.5 Abbott Recent Development
    • 7.21 MicroPort Medical Group
      • 7.21.1 MicroPort Medical Group Company Information
      • 7.21.2 MicroPort Medical Group Introduction and Business Overview
      • 7.21.3 MicroPort Medical Group Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
      • 7.21.4 MicroPort Medical Group Coronary Intervention Drug Eluting Stent Product Offerings
      • 7.21.5 MicroPort Medical Group Recent Development
    • 7.22 Philips
      • 7.22.1 Philips Company Information
      • 7.22.2 Philips Introduction and Business Overview
      • 7.22.3 Philips Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
      • 7.22.4 Philips Coronary Intervention Drug Eluting Stent Product Offerings
      • 7.22.5 Philips Recent Development
    • 7.23 Terumo Corporation
      • 7.23.1 Terumo Corporation Company Information
      • 7.23.2 Terumo Corporation Introduction and Business Overview
      • 7.23.3 Terumo Corporation Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
      • 7.23.4 Terumo Corporation Coronary Intervention Drug Eluting Stent Product Offerings
      • 7.23.5 Terumo Corporation Recent Development

  • 8 Industry Chain Analysis

    • 8.1 Coronary Intervention Drug Eluting Stent Industrial Chain
    • 8.2 Coronary Intervention Drug Eluting Stent Upstream Analysis
      • 8.2.1 Key Raw Materials
      • 8.2.2 Raw Materials Key Suppliers
      • 8.2.3 Manufacturing Cost Structure
    • 8.3 Midstream Analysis
    • 8.4 Downstream Analysis (Customers Analysis)
    • 8.5 Sales Model and Sales Channels
      • 8.5.1 Coronary Intervention Drug Eluting Stent Sales Model
      • 8.5.2 Sales Channel
      • 8.5.3 Coronary Intervention Drug Eluting Stent Distributors

  • 9 Research Findings and Conclusion

  • 10 Appendix

    • 10.1 Research Methodology
      • 10.1.1 Methodology/Research Approach
      • 10.1.2 Data Source
    • 10.2 Author Details
    • 10.3 Disclaimer
USD 3,950 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.